BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 27834582)

  • 21. Inhibition of Androgen Receptor Signaling Promotes Prostate Cancer Cell Migration via Upregulation of Annexin A1 Expression.
    Yang W; Wang K; Ma J; Hui K; Lv W; Ma Z; Huan M; Luo L; Wang X; Li L; Chen Y
    Arch Med Res; 2021 Feb; 52(2):174-181. PubMed ID: 33059953
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of miR-200c on the migration and invasion abilities of human prostate cancer Du145 cells and the corresponding mechanism.
    Shi R; Xiao H; Yang T; Chang L; Tian Y; Wu B; Xu H
    Front Med; 2014 Dec; 8(4):456-63. PubMed ID: 25363395
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Upregulated Annexin A1 promotes cellular invasion in triple-negative breast cancer.
    Okano M; Kumamoto K; Saito M; Onozawa H; Saito K; Abe N; Ohtake T; Takenoshita S
    Oncol Rep; 2015 Mar; 33(3):1064-70. PubMed ID: 25592491
    [TBL] [Abstract][Full Text] [Related]  

  • 24. GRP78 modulates cell adhesion markers in prostate Cancer and multiple myeloma cell lines.
    Cultrara CN; Kozuch SD; Ramasundaram P; Heller CJ; Shah S; Beck AE; Sabatino D; Zilberberg J
    BMC Cancer; 2018 Dec; 18(1):1263. PubMed ID: 30563499
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hypoxia inducible factor-1α-dependent epithelial to mesenchymal transition under hypoxic conditions in prostate cancer cells.
    Li M; Wang YX; Luo Y; Zhao J; Li Q; Zhang J; Jiang Y
    Oncol Rep; 2016 Jul; 36(1):521-7. PubMed ID: 27108616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The transcription factor ZEB1 promotes an aggressive phenotype in prostate cancer cell lines.
    Orellana-Serradell O; Herrera D; Castellon EA; Contreras HR
    Asian J Androl; 2018; 20(3):294-299. PubMed ID: 29271397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Gli-1 is crucial for hypoxia-induced epithelial-mesenchymal transition and invasion of breast cancer.
    Lei J; Fan L; Wei G; Chen X; Duan W; Xu Q; Sheng W; Wang K; Li X
    Tumour Biol; 2015 Apr; 36(4):3119-26. PubMed ID: 25501705
    [TBL] [Abstract][Full Text] [Related]  

  • 28. mTOR regulate EMT through RhoA and Rac1 pathway in prostate cancer.
    Chen X; Cheng H; Pan T; Liu Y; Su Y; Ren C; Huang D; Zha X; Liang C
    Mol Carcinog; 2015 Oct; 54(10):1086-95. PubMed ID: 25043657
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Androgen receptor as a regulator of ZEB2 expression and its implications in epithelial-to-mesenchymal transition in prostate cancer.
    Jacob S; Nayak S; Fernandes G; Barai RS; Menon S; Chaudhari UK; Kholkute SD; Sachdeva G
    Endocr Relat Cancer; 2014 Jun; 21(3):473-86. PubMed ID: 24812058
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Exosome carrying PSGR promotes stemness and epithelial-mesenchymal transition of low aggressive prostate cancer cells.
    Li Y; Li Q; Li D; Gu J; Qian D; Qin X; Chen Y
    Life Sci; 2021 Jan; 264():118638. PubMed ID: 33164833
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Upregulation of SATB1 is associated with prostate cancer aggressiveness and disease progression.
    Shukla S; Sharma H; Abbas A; MacLennan GT; Fu P; Danielpour D; Gupta S
    PLoS One; 2013; 8(1):e53527. PubMed ID: 23308245
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comprehensive study of gene and microRNA expression related to epithelial-mesenchymal transition in prostate cancer.
    Katz B; Reis ST; Viana NI; Morais DR; Moura CM; Dip N; Silva IA; Iscaife A; Srougi M; Leite KR
    PLoS One; 2014; 9(11):e113700. PubMed ID: 25409297
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NEDD9 crucially regulates TGF-β-triggered epithelial-mesenchymal transition and cell invasion in prostate cancer cells: involvement in cancer progressiveness.
    Morimoto K; Tanaka T; Nitta Y; Ohnishi K; Kawashima H; Nakatani T
    Prostate; 2014 Jun; 74(8):901-10. PubMed ID: 24728978
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of stage-specific embryonic antigen-4 (SSEA-4) defines spontaneous loss of epithelial phenotype in human solid tumor cells.
    Sivasubramaniyan K; Harichandan A; Schilbach K; Mack AF; Bedke J; Stenzl A; Kanz L; Niederfellner G; Bühring HJ
    Glycobiology; 2015 Aug; 25(8):902-17. PubMed ID: 25978997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Downregulated expression of hepatoma-derived growth factor inhibits migration and invasion of prostate cancer cells by suppressing epithelial-mesenchymal transition and MMP2, MMP9.
    Yang F; Yu N; Wang H; Zhang C; Zhang Z; Li Y; Li D; Yan L; Liu H; Xu Z
    PLoS One; 2018; 13(1):e0190725. PubMed ID: 29300772
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cysteine-rich secretory protein 3 plays a role in prostate cancer cell invasion and affects expression of PSA and ANXA1.
    Pathak BR; Breed AA; Apte S; Acharya K; Mahale SD
    Mol Cell Biochem; 2016 Jan; 411(1-2):11-21. PubMed ID: 26369530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TRPM4 channel is involved in regulating epithelial to mesenchymal transition, migration, and invasion of prostate cancer cell lines.
    Sagredo AI; Sagredo EA; Pola V; Echeverría C; Andaur R; Michea L; Stutzin A; Simon F; Marcelain K; Armisén R
    J Cell Physiol; 2019 Mar; 234(3):2037-2050. PubMed ID: 30343491
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Twist may be associated with invasion and metastasis of hypoxic NSCLC cells.
    Wei L; Sun JJ; Cui YC; Jiang SL; Wang XW; Lv LY; Xie L; Song XR
    Tumour Biol; 2016 Jul; 37(7):9979-87. PubMed ID: 26819207
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Annexin A1 May Induce Pancreatic Cancer Progression as a Key Player of Extracellular Vesicles Effects as Evidenced in the In Vitro MIA PaCa-2 Model System.
    Pessolano E; Belvedere R; Bizzarro V; Franco P; Marco I; Porta A; Tosco A; Parente L; Perretti M; Petrella A
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30518142
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A role for the dehydrogenase DHRS7 (SDR34C1) in prostate cancer.
    Seibert JK; Quagliata L; Quintavalle C; Hammond TG; Terracciano L; Odermatt A
    Cancer Med; 2015 Nov; 4(11):1717-29. PubMed ID: 26311046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.